-+ 0.00%
-+ 0.00%
-+ 0.00%

Immatics Announces Upcoming Presentations Across Its PRAME Franchise at ESMO Congress 2026

Barchart·07/17/2026 09:25:00
Listen to the news

Houston, Texas and Tuebingen, Germany, July 17, 2026 Immatics N.V. (NASDAQ: IMTX, “Immatics” or the “Company”), the global leader in precision targeting of PRAME with multiple clinical-stage programs spanning cell therapies and bispecifics, today announced three presentations at the European Society for Medical Oncology (ESMO) Congress 2026, to be held from October 23-27, 2026, in Madrid, Spain.

Read more at globenewswire.com

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.